1,844
Views
0
CrossRef citations to date
0
Altmetric
RSV

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

, , , , , , , & show all
Article: 2310916 | Received 06 Nov 2023, Accepted 24 Jan 2024, Published online: 18 Feb 2024

References

  • Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–14. doi:10.1016/S0140-6736(22)00478-0.
  • Savic M, Penders Y, Shi T, Branche A, Pirçon JY. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031. doi:10.1111/irv.13031.
  • Munro APS, Martinón-Torres F, Drysdale SB, Faust SN. The disease burden of respiratory syncytial virus in infants. Curr Opin Infect Dis. 2023;36(5):379–384. doi:10.1097/QCO.0000000000000952.
  • Centers for Disease Control and Prevention. Respiratory Syncytial Virus (RSV) immunizations. [accessed 2023 Sept 26]. https://www.cdc.gov/vaccines/vpd/rsv/index.html.
  • U.S. FOOD & DRUG. FDA approves first vaccine for pregnant individuals to prevent RSV in infants. [accessed 2023 Sept 26].https://www.fda.gov/news-events/press-announcements/fda-approves-first-vaccine-pregnant-individuals-prevent-rsv-infants.
  • Wilcox CR, Calvert A, Metz J, Kilich E, MacLeod R, Beadon K, Heath PT, Khalil A, Finn A, Snape MD, et al. Attitudes of pregnant women and healthcare professionals toward clinical trials and routine implementation of antenatal vaccination against respiratory syncytial virus: a multicenter questionnaire study. Pediatr Infect Dis J. 2019;38(9):944–951. doi:10.1097/INF.0000000000002384.
  • Lee Mortensen G, Harrod-Lui K. Parental knowledge about respiratory syncytial virus (RSV) and attitudes to infant immunization with monoclonal antibodies. Expert Rev Vaccines. 2022;21(10):1523–1531. doi:10.1080/14760584.2022.2108799.
  • Hurley LP, Allison MA, Kim L, O’Leary ST, Crane LA, Brtnikova M, Beaty BL, Allen KE, Poser S, Lindley MC, et al. Primary care physicians’ perspectives on respiratory syncytial virus (RSV) disease in adults and a potential RSV vaccine for adults. Vaccine. 2019;37(4):565–570. doi:10.1016/j.vaccine.2018.12.031.
  • Center for drug evaluation. Implied permission for clinical trials. [accessed 2023 Sept 26]. https://www.cde.org.cn/main/xxgk/listpage/4b5255eb0a84820cef4ca3e8b6bbe20c.
  • Schmoele-Thoma B, Zareba AM, Jiang Q, Maddur MS, Danaf R, Mann A, Eze K, Fok-Seang J, Kabir G, Catchpole A, et al. Vaccine efficacy in adults in a respiratory syncytial virus challenge study. N Engl J Med. 2022;386(25):2377–2386. doi:10.1056/NEJMoa2116154.
  • Wang B, Peng X, Li Y, Fu L, Tian T, Liang B, Sun Y, Chen Y, Wu X, Liu Q, et al. Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: a cross-sectional survey. J Infect Public Health. 2023;16(2):163–170. doi:10.1016/j.jiph.2022.12.010.
  • Riccò M, Ferraro P, Peruzzi S, Zaniboni A, Ranzieri S. Respiratory syncytial virus: knowledge, attitudes and beliefs of general practitioners from North-Eastern Italy (2021). Pediatr Rep. 2022;14(2):147–165. doi:10.3390/pediatric14020021.
  • Wendlandt R, Cowling BJ, Chen Y, Havers F, Shifflett P, Song Y, Zhang R, Iuliano D, Xu C, Yu H, et al. Knowledge, attitudes and practices related to the influenza virus and vaccine among older adults in Eastern China. Vaccine. 2018;36(19):2673–2682. doi:10.1016/j.vaccine.2018.03.052.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–228. doi:10.1038/s41591-020-1124-9.
  • Sumner KM, Duca LM, Arriola CS, Neyra J, Soto G, Romero C, Tinoco Y, Nogareda F, Matos E, Chavez V, et al. Knowledge, attitudes, and practices associated with frequent influenza vaccination among healthcare personnel in Peru, 2016–2018. Vaccine. 2023;14:100314. Published 2023 May 12. doi:10.1016/j.jvacx.2023.100314.
  • Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. doi:10.2196/jmir.6.3.e34.
  • Karen G, Barbara KR, Viswanath K. Health behavior and health education: theory, research, and practice. 4th ed. San Francisco (CA): Jossey-Bass; 2008.
  • Kherfan T, Sallam M. Prospective attitudes towards Respiratory Syncytial Virus (RSV) vaccination: validation of a survey instrument among young females in Jordan pending vaccine Authorization. Vaccines (Basel). 2023;11(8):1386. doi:10.3390/vaccines11081386.
  • Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021;150:106694. doi:10.1016/j.ypmed.2021.106694.
  • Kampmann B, Madhi SA, Munjal I, Simões EAF, Pahud BA, Llapur C, Baker J, Pérez Marc G, Radley D, Shittu E, et al. Bivalent prefusion F vaccine in pregnancy to prevent RSV Illness in Infants. N Engl J Med. 2023;388(16):1451–1464. doi:10.1056/NEJMoa2216480.
  • Melgar M, Britton A, Roper LE, Talbot HK, Long SS, Kotton CN, Havers FP. Use of respiratory syncytial virus vaccines in older adults: recommendations of the advisory committee on immunization practices – United States, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(29):793–801. doi:10.15585/mmwr.mm7229a4.
  • Centers for Disease Control and Prevention. CDC Vaccine Price List. [accessed 2023 Sept 26]. https://www.cdc.gov/vaccines/programs/vfc/awardees/vaccine-management/price-list/index.html.
  • Zeevat F, Luttjeboer J, Paulissen JHJ, van der Schans J, Beutels P, Boersma C, Postma MJ, Nair H, Campbell H, Openshaw P, et al. Exploratory analysis of the economically justifiable price of a hypothetical RSV vaccine for older adults in the Netherlands and the United Kingdom. J Infect Dis. 2022;226(Suppl 1):S102–S109. doi:10.1093/infdis/jiab118.
  • Centers for Disease Control and Prevention. RSV prevention. [accessed 2023 Sept 26]. https://www.cdc.gov/rsv/about/prevention.html.
  • de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ. Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020;396(10255):898–908. doi:10.1016/S0140-6736(20)31558-0.
  • Wang G, Yao Y, Wang Y, Gong J, Meng Q, Wang H, Wang W, Chen X, Zhao Y. Determinants of COVID-19 vaccination status and hesitancy among older adults in China. Nat Med. 2023;29(3):623–631. doi:10.1038/s41591-023-02241-7.
  • Yang L, Ji L, Wang Q, Yang G, Xiu S, Cui T, Shi N, Zhu L, Xu X, Jin H, et al. Understanding drivers of vaccine hesitancy during the COVID-19 pandemic among older adults in Jiangsu Province, China: cross-sectional survey. JMIR Form Res. 2023;7:e39994. doi:https://doi.org/10.2196/39994.
  • Zhang D, Zhou W, Poon PK, Kwok KO, Chui TW, Hung PHY, Ting BYT, Chan DCC, Wong SYS. Vaccine resistance and hesitancy among older adults who live alone or only with an older partner in community in the early stage of the fifth wave of COVID-19 in Hong Kong. Vaccines (Basel). 2022;10(7):1118. doi:10.3390/vaccines10071118.